Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline SR Bornstein, B Allolio, W Arlt, A Barthel, A Don-Wauchope, GD Hammer, ... The Journal of Clinical Endocrinology & Metabolism 101 (2), 364-389, 2016 | 1650 | 2016 |
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline PW Speiser, R Azziz, LS Baskin, L Ghizzoni, TW Hensle, DP Merke, ... The Journal of Clinical Endocrinology & Metabolism 95 (9), 4133-4160, 2010 | 1437 | 2010 |
Congenital adrenal hyperplasia DP Merke, SR Bornstein The Lancet 365 (9477), 2125-2136, 2005 | 1042 | 2005 |
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline PW Speiser, W Arlt, RJ Auchus, LS Baskin, GS Conway, DP Merke, ... The Journal of Clinical Endocrinology & Metabolism 103 (11), 4043-4088, 2018 | 1000 | 2018 |
Congenital adrenal hyperplasia D El-Maouche, W Arlt, DP Merke The Lancet 390 (10108), 2194-2210, 2017 | 561 | 2017 |
Modified-release hydrocortisone to provide circadian cortisol profiles M Debono, C Ghobadi, A Rostami-Hodjegan, H Huatan, MJ Campbell, ... The Journal of Clinical Endocrinology & Metabolism 94 (5), 1548-1554, 2009 | 386 | 2009 |
Puberty-related influences on brain development JN Giedd, LS Clasen, R Lenroot, D Greenstein, GL Wallace, S Ordaz, ... Molecular and cellular endocrinology 254, 154-162, 2006 | 373 | 2006 |
Congenital adrenal hyperplasia—current insights in pathophysiology, diagnostics, and management HL Claahsen-van der Grinten, PW Speiser, SF Ahmed, W Arlt, RJ Auchus, ... Endocrine reviews 43 (1), 91-159, 2022 | 333 | 2022 |
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia GP Finkielstain, MS Kim, N Sinaii, M Nishitani, C Van Ryzin, SC Hill, ... The Journal of Clinical Endocrinology & Metabolism 97 (12), 4429-4438, 2012 | 333 | 2012 |
ESPE-LWPES GnRH Analogs Consensus Conference Group JC Carel, EA Eugster, A Rogol, L Ghizzoni, MR Palmert, F Antoniazzi, ... Consensus statement on the use of gonadotropin-releasing hormone analogs in …, 2009 | 309 | 2009 |
Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency DP Merke, GP Chrousos, G Eisenhofer, M Weise, MF Keil, AD Rogol, ... New England Journal of Medicine 343 (19), 1362-1368, 2000 | 306 | 2000 |
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency DP Merke, RJ Auchus New England Journal of Medicine 383 (13), 1248-1261, 2020 | 246 | 2020 |
Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency DP Merke, SR Bornstein, NA Avila, GP Chrousos Annals of Internal Medicine 136 (4), 320-334, 2002 | 236 | 2002 |
Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital … DP Merke, MF Keil, JV Jones, J Fields, S Hill, GB Cutler Jr The Journal of Clinical Endocrinology & Metabolism 85 (3), 1114-1120, 2000 | 219 | 2000 |
Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency AF Turcu, AT Nanba, R Chomic, SK Upadhyay, TJ Giordano, JJ Shields, ... European journal of endocrinology 174 (5), 601-609, 2016 | 211 | 2016 |
Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency GP Finkielstain, W Chen, SP Mehta, FK Fujimura, RM Hanna, ... The Journal of Clinical Endocrinology & Metabolism 96 (1), E161-E172, 2011 | 207 | 2011 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose … DJ Straus, JJ Gaynor, J Myers, DP Merke, J Caravelli, D Chapman, ... Journal of Clinical Oncology 8 (7), 1173-1186, 1990 | 192 | 1990 |
Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications E Charmandari, M Weise, SR Bornstein, G Eisenhofer, MF Keil, ... The Journal of Clinical Endocrinology & Metabolism 87 (5), 2114-2120, 2002 | 188 | 2002 |
A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia A Mallappa, N Sinaii, P Kumar, MJ Whitaker, LA Daley, D Digweed, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), 1137-1145, 2015 | 178 | 2015 |
Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency DP Merke The Journal of Clinical Endocrinology & Metabolism 93 (3), 653-660, 2008 | 169 | 2008 |